Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis

Clinical trial NCT02129777 · COMPLETED

Trial details

NCT number: NCT02129777
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2014-06-01
Primary completion: 2015-09-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.